Tigenix SA

Where the EU money came from

Funding by EU programme. Amounts are Tigenix SA's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Tigenix SA led 1 of them as coordinator. Each links to the official record.

• SEPCELLCoordinator

  Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje

  Horizon 2020 · 2015–2022 · Project on CORDIS ↗

  €1.2Mtheir share
• REGENER-ARPartner

  Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis

  FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

  €1.6Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Tigenix NVBelgium · 2 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• Centro de Investigaciones Energeticas Medioambientales y TecnologicasSpain · 1 shared project
• Centre hospitalier universitaire de LimogesFrance · 1 shared project
• Servicio Madrileno de SaludSpain · 1 shared project
• Zabala Innovation Consulting SASpain · 1 shared project
• Mondragon Assembly Sociedad CooperativaSpain · 1 shared project
• Cliniques Universitaires Saint-Luc ASBLBelgium · 1 shared project
• Sistemic Scotland LimitedUnited Kingdom · 1 shared project
• Farma-Cros Iberica S.l.Spain · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• critical care medicine
• immunology
• pharmaceutical drugs
• pneumology
• rheumatology
• stem cells
• vascular diseases